David Bucienski on Nostr: The Monoclonal antibodies tech we all heard about often during the plandemic is being ...
The Monoclonal antibodies tech we all heard about often during the plandemic is being used to active a 3rd set of teeth. Our adult teeth are our 2nd set and we have a 3rd that are forever dormant. Human trials are starting soon.
New drug to regenerate lost teeth | ScienceDaily
https://www.sciencedaily.com/releases/2021/03/210329122852.htmPublished at
2024-06-13 02:51:41Event JSON
{
"id": "828e0001f2a248a30e925c7bc9d78e6fcfd69b64deacabf934b461e1de10e77c",
"pubkey": "6fbd41613cebecbc9bb6881833cf22c191268fb75ffde54c7f50987a5ce563d8",
"created_at": 1718247101,
"kind": 1,
"tags": [
[
"proxy",
"https://noauthority.social/users/DavidB/statuses/112607042054488867",
"activitypub"
]
],
"content": "The Monoclonal antibodies tech we all heard about often during the plandemic is being used to active a 3rd set of teeth. Our adult teeth are our 2nd set and we have a 3rd that are forever dormant. Human trials are starting soon. \n\nNew drug to regenerate lost teeth | ScienceDaily\nhttps://www.sciencedaily.com/releases/2021/03/210329122852.htm",
"sig": "b07341c35d2d31c4bb6159c82678f795b144d53c0a451ea897ccfa2a7dcd48527e5b998c8dffd2e2dea9908d4af9d671625c199e0735c12e86f196b5d200f6d9"
}